Navin Fluorine International Limited has informed the Exchange about Schedule of meet
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Navin Fluorine has informed the exchange about an analyst/investor meet scheduled for August 5, 2025, attaching its July 2025 investor presentation. Q1FY26 results show consolidated revenue of Rs. 725.4 Cr (+39% YoY) and operating EBITDA of Rs. 206.8 Cr (+106% YoY), with EBITDA margin expanding sharply by 935 bps YoY to 28.5%. All three business verticals grew strongly: HPP +45%, Specialty Chemicals +35%, and CDMO +23%. The company highlighted key capex milestones — Rs. 450 Cr AHF facility at Dahej to commission by end-Q2FY26 and Rs. 160 Cr cGMP4 Phase-1 to commission by end-Q3FY26 — alongside a robust FY26 order book across segments.
Strong Q1FY26 numbers with margin expansion and visible order pipeline should support positive sentiment. Forward-looking triggers (Dahej AHF, cGMP4 commissioning) and growth in CDMO orders provide near-term catalysts for the stock.